多系统性缩伪装成抗药性正静止性低血压
Manami Yamaoka1, Shuichiro Neshige1, Kenta Sasaki1
1Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, JPN.
这一案例凸显了耐药性和静止性低血压可能表明早期多重系统缩 (MSA),特别是小脑类型 (MSA-C),甚至在其他神经退行症状出现之前.
科学领域:
- 神经学 神经学
- 神经退行性疾病 神经退行性疾病
背景情况:
- 复发性昏迷和静止性低血压的诊断可能具有挑战性.
- 耐药性症状需要对潜在的神经疾病进行彻底的调查.
研究的目的:
- 给出一个可能的小脑类型多重系统缩 (MSA-C) 病例,最初呈现出耐药性昏和静止性低血压.
- 强调在对不明原因昏迷的差异诊断中考虑MSA的重要性.
主要方法:
- 54岁男性的临床表现,有两年的复发性昏迷病史.
- 诊断工作包括血液检测,心脏评估,脑CT,Schellong测试,脑MRI和多巴胺输送器单光子发射计算断层扫描 (DAT-SPECT).
主要成果:
- 对于昏迷的初始治疗是无效的.
- 施勒龙测试呈阳性,表明正静性低血压.
- 大脑MRI揭示了小马的"十字标志",DAT-SPECT显示了基底质的吸收减少.
- 确立了可能的MSA-C的诊断.
结论:
- 持续的正静性低血压和昏迷,即使没有明显的神经退行性症状,也应该促使人们考虑多重系统缩 (MSA).
- 早期诊断MSA-C对于及时管理和患者护理至关重要.
更多相关视频
06:45Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
10:41Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
相关概念视频
Antihypertensive Drugs: Potassium-Sparing Diuretics
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alterations in Blood Pressure
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Parkinson's Disease: Overview
